Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for XyloCor Therapeutics

    Client Virtual Booth

    XYLOCOR THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    XyloCor Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Liberty Ridge Drive, Suite 120 Wayne, PA 19087
    Telephone
    Telephone
    888-290-0081
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://xylocor.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xylocor-therapeutics-inc./
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    XyloCor Presents Phase 2 Data Highlighting Safety and Efficacy of XC001
    XyloCor Presents Phase 2 Data Highlighting Safety and Efficacy of XC001

    https://www.businesswire.com/news/home/20230824534961/en

    BUSINESSWIRE
    25 Aug 2023
    Share Share
    Results from XyloCor’s Phase 1 Portion of EXACT Trial of XC001 Published
    Results from XyloCor’s Phase 1 Portion of EXACT Trial of XC001 Published

    https://www.businesswire.com/news/home/20230803967906/en

    BUSINESSWIRE
    03 Aug 2023
    Share Share
    XyloCor Reports Sustained Results of Phase 2 EXACT Clinical Trial of XC001
    XyloCor Reports Sustained Results of Phase 2 EXACT Clinical Trial of XC001

    https://www.businesswire.com/news/home/20230718368716/en

    BUSINESSWIRE
    18 Jul 2023
    Share Share
    XyloCor reports positive data from refractory angina gene therapy trial
    XyloCor reports positive data from refractory angina gene therapy trial

    https://www.clinicaltrialsarena.com/news/xylocor-refractory-angina-gene-therapy/

    CLINICAL TRIALS ARENA
    27 Jan 2023
    Share Share
    XyloCor Reports Positive Safety Results from Phase 2 EXACT Trial of XC001
    XyloCor Reports Positive Safety Results from Phase 2 EXACT Trial of XC001

    https://www.businesswire.com/news/home/20230126005099/en

    BUSINESSWIRE
    26 Jan 2023
    Share Share
    XyloCor gene therapy hits goals, paving way for pivotal trial
    XyloCor gene therapy hits goals, paving way for pivotal trial

    https://www.fiercebiotech.com/biotech/xylocor-gene-therapy-hits-goals-paving-way-phase-3-cardiovascular-space-no-current

    Gabrielle Masson FIERCE BIOTECH
    26 Jan 2023
    Share Share
    XyloCor Achieves Target Enrollment in PII EXACT Study of XC001 Gene Therapy
    XyloCor Achieves Target Enrollment in PII EXACT Study of XC001 Gene Therapy

    https://www.businesswire.com/news/home/20220628005186/en

    BUSINESSWIRE
    28 Jun 2022
    Share Share
    XyloCor to Present Prelim Clinical Data from PI Portion of PI/II Study of XC001
    XyloCor to Present Prelim Clinical Data from PI Portion of PI/II Study of XC001

    https://www.businesswire.com/news/home/20220518005035/en

    BUSINESSWIRE
    18 May 2022
    Share Share
    XyloCor begins Phase II part of EXACT trial for refractory angina
    XyloCor begins Phase II part of EXACT trial for refractory angina

    https://www.clinicaltrialsarena.com/news/xylocor-exact-trial-phaseii/

    CLINICAL TRIAL ARENA
    28 Jul 2021
    Share Share
    XyloCor Commences Phase 2 Component of Phase 1/2 EXACT Study of XC001
    XyloCor Commences Phase 2 Component of Phase 1/2 EXACT Study of XC001

    https://www.businesswire.com/news/home/20210727005177/en

    PR NEWSWIRE
    27 Jul 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search